Trial Details

COMPLETED
Basic Information
Clinical ID c532
Identifier NCT00791557
Trial Title Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Pyoderma Gangrenosum|Crohn's Disease|Ulcerative Colitis|Inflammatory Bowel Disease
Interventions DRUG: Infliximab
Participant Information
Sponsor University Hospitals Cleveland Medical Center
City Cleveland
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase -
Time Information
Start Date 2025-10-08
Primary Completion Date 2025-12-09
Completion Date 2025-02-10